Crypto Specialist Bitwise’s First-Ever Spot Ethereum ETF Receives Key SEC Approval
Firm expects many bitcoin ETF investors will diversify their crypto holdings if the fund launches. SAN FRANCISCO–(BUSINESS WIRE)–Bitwise Asset Management,... Read more.
Pei enters the MSCI COLCAP index
BOGOTA, Colombia–(BUSINESS WIRE)–Pei, the leading real estate investment trust in Colombia, has been selected to be part of the MSCI COLCAP, a stock... Read more.
Oklo Partners with Wyoming Hyperscale to Deliver 100 Megawatts to its Data Centers
Oklo and Wyoming Hyperscale signed a non-binding letter of intent to collaborate on a 20-year Power Purchase Agreement. Wyoming Hyperscale will aim to use Oklo’s... Read more.
NW Natural Holdings and NW Natural CEO David H. Anderson Announces Retirement
Board of Directors Announces CEO Succession Plan PORTLAND, Ore.–(BUSINESS WIRE)–NW Natural Holding Company (NYSE: NWN) (NW Natural Holdings) and NW Natural... Read more.
Flatiron Health Announces Research to Be Presented at American Society of Clinical Oncology 2024 Annual Meeting
Advancing oncology and bridging healthcare gaps NEW YORK–(BUSINESS WIRE)–Flatiron Health today announced its significant presence at this year’s American... Read more.
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms
PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #ASCO—Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology... Read more.
Aulos Bioscience Provides Positive Interim Phase 1/2 Data From AU-007 at 2024 ASCO Annual Meeting
Preliminary results show durable anti-tumor activity in multiple solid tumor types among heavily pre-treated patients, including patients whose tumors have progressed... Read more.
TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in Germany
Durable survival effect observed in the largest prospective, non-interventional study completed examining TTFields therapy use in newly diagnosed GBM Topline data... Read more.
Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
Emerging clinical pharmacokinetic and safety profiles of Bicycle Toxin Conjugates® demonstrate differentiation compared to antibody drug conjugates Trial-in-progress... Read more.
Stellar Bancorp, Inc. Declares Quarterly Dividend and New Share Repurchase Program
HOUSTON–(BUSINESS WIRE)–Stellar Bancorp, Inc. (the “Company”) (NYSE: STEL) today announced that on May 23, 2024, its Board of Directors declared... Read more.